VALUE-ADDED CHAIN OF A NEW PHARMACEUTICAL PRODUCT

Milena Filipova () and Yulia Nedelcheva ()
Additional contact information
Milena Filipova: South-West University “Neofit Rilski”, Blagoevgrad, Department of Management and marketing
Yulia Nedelcheva: South-West University “Neofit Rilski”, Blagoevgrad, Department of Management and marketing

Economics and Management, 2022, vol. 19, issue 1, 65-78

Abstract: The aim of our study is to present the value-added chain for a new pharmaceutical product. Shifts in society are setting new expectations to pharmaceutical products. By critically using the results of leading researchers, we form the modern value-added chain. The results of our study determine the most complex value-added chain for a new pharmaceutical product. The requirements by competent authorities for safe, efficient and quality pharmaceutical products determine the dynamics of value-added chain steps. The safety and efficacy of a new pharmaceutical product reduce the importance of other factors such as innovative and affordable product.

Keywords: pharmaceutical industry; step-by-step production (search for similar items in EconPapers)
JEL-codes: I11 L23 L65 (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://em.swu.bg/images/SpisanieIkonomikaupload/Sp ... dded%20chain%203.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:neo:journl:v:19:y:2022:i:1:p:65-78

DOI: 10.37708/em.swu.v19i1.6

Access Statistics for this article

More articles in Economics and Management from Faculty of Economics, SOUTH-WEST UNIVERSITY "NEOFIT RILSKI", BLAGOEVGRAD Contact information at EDIRC.
Bibliographic data for series maintained by Vladislav Krastev ().